These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31898798)

  • 1. Role of linezolid combination therapy for serious infections: review of the current evidence.
    Chen H; Du Y; Xia Q; Li Y; Song S; Huang X
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1043-1052. PubMed ID: 31898798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linezolid: a review of its properties, function, and use in critical care.
    Hashemian SMR; Farhadi T; Ganjparvar M
    Drug Des Devel Ther; 2018; 12():1759-1767. PubMed ID: 29950810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: emerging problems and new prospects for management.
    Noskin GA
    Ann Acad Med Singap; 2001 May; 30(3):320-31. PubMed ID: 11455748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linezolid: a review of its use in the management of serious gram-positive infections.
    Perry CM; Jarvis B
    Drugs; 2001; 61(4):525-51. PubMed ID: 11324682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linezolid in children: recent patents and advances.
    Velissariou IM
    Recent Pat Antiinfect Drug Discov; 2007 Jan; 2(1):73-7. PubMed ID: 18221164
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Wang S; Cai C; Shen Y; Sun C; Shi Q; Wu N; Zheng S; Qian J; Zhang R; Zhou H
    Front Microbiol; 2021; 12():729900. PubMed ID: 34489919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of the classical G2576U mutation in linezolid resistant Staphylococcus aureus along with isolation of linezolid resistant Enterococcus faecium from a patient on short-term linezolid therapy: first report from India.
    Rai S; Niranjan DK; Kaur T; Singh NP; Hada V; Kaur IR
    Indian J Med Microbiol; 2015; 33(1):21-4. PubMed ID: 25559997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
    Zhanel GG; Love R; Adam H; Golden A; Zelenitsky S; Schweizer F; Gorityala B; Lagacé-Wiens PR; Rubinstein E; Walkty A; Gin AS; Gilmour M; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2015 Feb; 75(3):253-70. PubMed ID: 25673021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance.
    Rybak JM; Marx K; Martin CA
    Pharmacotherapy; 2014 Nov; 34(11):1198-208. PubMed ID: 25266820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains].
    Efe S; Sinirtaş M; Ozakin C
    Mikrobiyol Bul; 2009 Oct; 43(4):639-43. PubMed ID: 20084917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Linezolid-resistant Enterococcus faecium: the first G2576T mutation in Turkey].
    Afşar I; Barış I; Sener AG; Köksal V; Demirci M
    Mikrobiyol Bul; 2012 Jul; 46(3):516-8. PubMed ID: 22951666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
    Napolitano LM
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linezolid Pharmacia Corp.
    Barrett JF
    Curr Opin Investig Drugs; 2000 Oct; 1(2):181-7. PubMed ID: 11249571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tedizolid: a new oxazolidinone antimicrobial.
    Kisgen JJ; Mansour H; Unger NR; Childs LM
    Am J Health Syst Pharm; 2014 Apr; 71(8):621-33. PubMed ID: 24688035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Considerations for CNS Infections Caused by Vancomycin-Resistant
    Lee BJ; Vu BN; Seddon AN; Hodgson HA; Wang SK
    Ann Pharmacother; 2020 Dec; 54(12):1243-1251. PubMed ID: 32506921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus.
    Scheinfeld N
    J Drugs Dermatol; 2007 Jan; 6(1):97-103. PubMed ID: 17373167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibiotic therapy: progress and development of resistance].
    Adam D
    Internist (Berl); 2006 Jul; 47(7):758-63. PubMed ID: 16703381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro activity of linezolid and dalbavancin against vancomycin-resistant enterococci].
    Aktaş G; Bozdoğan B; Derbentli S
    Mikrobiyol Bul; 2012 Jul; 46(3):359-65. PubMed ID: 22951648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.